Current update on combined hepatocellular-cholangiocarcinoma

European Journal of Radiology Open

Volumn 1, Issue 1, 2014, Pages 40-48

  Maximin, Suresh ^a   Ganeshan, Dhakshina Moorthy ^e   Shanbhogue, Alampady K ^d   Dighe, Manjiri K ^a   Yeh, Matthew M ^b   Kolokythas, Orpheus ^c   Bhargava, Puneet ^f   Lalwani, Neeraj ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c CANTONAL HOSPITAL WINTERTHUR   (Switzerland)

^d BETH ISRAEL MEDICAL CENTER   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

Cholangiocarcinoma; Cirrhosis; Computed tomography; Hepatocellular carcinoma; Magnetic resonance imaging

Indexed keywords

BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CANCER PROGNOSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; GENETIC ANALYSIS; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; IMMUNOPATHOLOGY; MOLECULAR BIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 84921951773     PISSN: None     EISSN: 23520477     Source Type: Journal    
DOI: 10.1016/j.ejro.2014.07.001     Document Type: Review

References (45)

1. Allen RA, Lisa JR. Combined liver cell and bile duct carcinoma. Am JPathol 1949;25(4):647-55.
2. Jarnagin WR, Weber S, Tickoo SK, Koea JB, Obiekwe S, Fong Y, et al.Combined hepatocellular and cholangiocarcinoma: demographic, clinical,and prognostic factors. Cancer 2002;94(7):2040-6.
3. Yeh MM. Pathology of combined hepatocellular-cholangiocarcinoma. JGastroenterol Hepatol 2010;25(9):1485-92.
4. Goodman ZD, Ishak KG, Langloss JM, Sesterhenn IA, Rabin L. Combinedhepatocellular-cholangiocarcinoma. A histologic and immunohistochemi-cal study. Cancer 1985;55(1):124-35.
5. Theise ND, Nakashima O, Park YN, Nakanuma Y. Combinedhepatocellular-cholangiocarcinoma. In: WHO classification of tumours ofthe digestive system. 4th ed. Lyon: IARC Press; 2010.
6. Lee WS, Lee KW, Heo JS, Kim SJ, Choi SH, Kim YI, et al.Comparison of combined hepatocellular and cholangiocarcinoma with hep-atocellular carcinoma and intrahepatic cholangiocarcinoma. Surg Today 2006;36(10):892-7.
7. Zuo HQ, Yan LN, Zeng Y, Yang JY, Luo HZ, Liu JW, et al. Clinicopatholog-ical characteristics of 15 patients with combined hepatocellular carcinomaand cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2007;6(2):161-5.
8. Cazals-Hatem D, Rebouissou S, Bioulac-Sage P, Bluteau O, Blanche H,Franco D, et al. Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas. J Hepatol 2004;41(2):292-8.
9. Lee JH, Chung GE, Yu SJ, Hwang SY, Kim JS, Kim HY, et al. Long-term prognosis of combined hepatocellular and cholangiocarcinoma aftercurative resection comparison with hepatocellular carcinoma and cholan-giocarcinoma. J Clin Gastroenterol 2011;45(1):69-75.
10. Liu CL, Fan ST, Lo CM, Ng IO, Lam CM, Poon RT, et al. Hepatic resectionfor combined hepatocellular and cholangiocarcinoma. Arch Surg (Chicago,IL: 1960) 2003;138(1):86-90.
11. Kassahun WT, Hauss J. Management of combined hepatocellular andcholangiocarcinoma. Int J Clin Pract 2008;62(8):1271-8.
12. Kim JH, Yoon HK, Ko GY, Gwon DI, Jang CS, Song HY, et al. Non-resectable combined hepatocellular carcinoma and cholangiocarcinoma:analysis of the response and prognostic factors after transcatheter arterialchemoembolization. Radiology 2010;255(1):270-7.
13. Aoki K, Takayasu K, Kawano T, Muramatsu Y, Moriyama N, Wakao F,et al. Combined hepatocellular carcinoma and cholangiocarcinoma: clinicalfeatures and computed tomographic findings. Hepatology (Baltimore, MD)1993;18(5):1090-5.
14. Koh KC, Lee H, Choi MS, Lee JH, Paik SW, Yoo BC, et al.Clinicopathologic features and prognosis of combined hepatocellularcholangiocarcinoma. Am J Surg 2005;189(1):120-5.
15. Yano Y, Yamamoto J, Kosuge T, Sakamoto Y, Yamasaki S, Shimada K,et al. Combined hepatocellular and cholangiocarcinoma: a clinicopatho-logic study of 26 resected cases. Jpn J Clin Oncol 2003;33(6):283-7.
16. Panjala C, Senecal DL, Bridges MD, Kim GP, Nakhleh RE,Nguyen JH, et al. The diagnostic conundrum and liver transplantationoutcome for combined hepatocellular-cholangiocarcinoma. Am J Trans-plant 2010;10(5):1263-7.
17. Ebied O, Federle MP, Blachar A, Brancatelli G, Grazioli L, Cazals-HatemD, et al. Hepatocellular-cholangiocarcinoma: helical computed tomogra-phy findings in 30 patients. J Comput Assist Tomogr 2003;27(2):117-24.
18. Bhagat V, Javle M, Yu J, Agrawal A, Gibbs JF, Kuvshinoff B, et al. Com-bined hepatocholangiocarcinoma: case-series and review of literature. IntJ Gastrointest Cancer 2006;37(1):27-34.
19. Maeda T, Adachi E, Kajiyama K, Sugimachi K, Tsuneyoshi M. Com-bined hepatocellular and cholangiocarcinoma: proposed criteria accordingto cytokeratin expression and analysis of clinicopathologic features. HumPathol 1995;26(9):956-64.
20. Tickoo SK, Zee SY, Obiekwe S, Xiao H, Koea J, Robiou C, et al. Combinedhepatocellular-cholangiocarcinoma: a histopathologic, immunohistochem-ical, and in situ hybridization study. Am J Surg Pathol 2002;26(8):989-97.
21. Shirakawa H, Kuronuma T, Nishimura Y, Hasebe T, Nakano M, Goto-hda N, et al. Glypican-3 is a useful diagnostic marker for a component ofhepatocellular carcinoma in human liver cancer. Int J Oncol 2009;34(3):649-56.
22. Durnez A, Verslype C, Nevens F, Fevery J, Aerts R, Pirenne J, et al.The clinicopathological and prognostic relevance of cytokeratin 7 and 19expression in hepatocellular carcinoma. A possible progenitor cell origin.Histopathology 2006;49(2):138-51.
23. Wong N, Li L, Tsang K, Lai PB, To KF, Johnson PJ. Frequent loss of chro-mosome 3p and hypermethylation of RASSF1A in cholangiocarcinoma. JHepatol 2002;37(5):633-9.
24. Sugimachi K, Taguchi K, Aishima S, Tanaka S, Shimada M, KajiyamaK, et al. Altered expression of beta-catenin without genetic mutation inintrahepatic cholangiocarcinoma. Mod Pathol 2001;14(9):900-5.
25. Wu PC, Fang JW, Lau VK, Lai CL, Lo CK, Lau JY. Classificationof hepatocellular carcinoma according to hepatocellular and biliary dif-ferentiation markers. Clinical and biological implications. Am J Pathol1996;149(4):1167-75.
26. Fujii H, Zhu XG, Matsumoto T, Inagaki M, Tokusashi Y, Miyokawa N, et al.Genetic classification of combined hepatocellular-cholangiocarcinoma.Hum Pathol 2000;31(9):1011-7.
27. Choi BI, Han JK, Kim YI, Kim HC, Park JH, Kim CW, et al. Com-bined hepatocellular and cholangiocarcinoma of the liver: sonography,CT, angiography, and iodized-oil CT with pathologic correlation. AbdomImaging 1994;19(1):43-6.
28. Sanada Y, Shiozaki S, Aoki H, Takakura N, Yoshida K, Yamaguchi Y. Aclinical study of 11 cases of combined hepatocellular-cholangiocarcinomaassessment of enhancement patterns on dynamics computed tomographybefore resection. Hepatol Res 2005;32(3):185-95.
29. Lin G, Toh CH, Wu RC, Ko SF, Ng SH, Chou WC, et al. Com-bined hepatocellular cholangiocarcinoma: prognostic factors investigatedby computed tomography/magnetic resonance imaging. Int J Clin Pract2008;62(8):1199-205.
30. Hashimoto T, Nakamura H, Hori S, Tomoda K, Mitani T, Murakami T, et al.MR imaging of mixed hepatocellular and cholangiocellular carcinoma.Abdom Imaging 1994;19(5):430-2.
31. Murakami T, Kim T, Tomoda K, Narumi Y, Sakon M, Wakasa K, et al.Combined hepatocellular and cholangiocellular carcinoma. Radiat Med1997;15(4):243-6.
32. Jeon TY, Kim SH, Lee WJ, Lim HK. The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation ofscirrhous hepatocellular carcinoma and cholangiocarcinoma with or with-out hepatocellular carcinoma. Abdom Imaging 2010;35(3):337-45.
33. Willekens I, Hoorens A, Geers C, Op de Beeck B, Vandenbroucke F, deMey J. Combined hepatocellular and cholangiocellular carcinoma present-ing with radiological characteristics of focal nodular hyperplasia. World JGastroenterol 2009;15(31):3940-3.
34. de Campos RO, Semelka RC, Azevedo RM, Ramalho M, Heredia V, ArmaoDM, et al. Combined hepatocellular carcinoma-cholangiocarcinoma:report of MR appearance in eleven patients. J Magn Reson Imaging2012;36(5):1139-47.
35. Huppertz A, Haraida S, Kraus A, Zech CJ, Scheidler J, Breuer J,et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT - initialobservations. Radiology 2005;234(2):468-78.
36. Hwang J, Kim YK, Park MJ, Lee MH, Kim SH, Lee WJ, et al. Differentiat-ing combined hepatocellular and cholangiocarcinoma from mass-formingintrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI. JMagn Reson Imaging 2012;36(4):881-9.
37. Danet IM, Semelka RC, Leonardou P, Braga L, Vaidean G, Woosley JT,et al. Spectrum of MRI appearances of untreated metastases of the liver.Am J Roentgenol 2003;181(3):809-17.
38. Kierans AS, Leonardou P, Hayashi P, Brubaker LM, Elazzazi M, Shaikh F,et al. MRI findings of rapidly progressive hepatocellular carcinoma. MagnReson Imaging 2010;28(6):790-6.
39. Portolani N, Baiocchi GL, Coniglio A, Piardi T, Grazioli L, BenettiA, et al. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience. Ann Surg Oncol 2008;15(7):1880-90.
40. Kim KH, Lee SG, Park EH, Hwang S, Ahn CS, Moon DB, et al. Sur-gical treatments and prognoses of patients with combined hepatocellularcarcinoma and cholangiocarcinoma. Ann Surg Oncol 2009;16(3):623-9.
41. Taguchi J, Nakashima O, Tanaka M, Hisaka T, Takazawa T, Kojiro M. Aclinicopathological study on combined hepatocellular and cholangiocarci-noma. J Gastroenterol Hepatol 1996;11(8):758-64.
42. Wang J, Wang F, Kessinger A. Outcome of combined hepatocellular andcholangiocarcinoma of the liver. J Oncol 2010;2010.
43. Perkins JD. Transplanted patients with combined hepatocellular-cholangiocarcinoma: now what? Liver Transplant 2007;13(10):1465-6.
44. Toh CH, Cheung YC, Ng SH, Lin CY, Chan SC, Ng KK. Com-bined hepatocellular-cholangiocarcinoma: a case report. Int J Clin Pract2004;58(12):1170-3.
45. Fukukura Y, Taguchi J, Nakashima O, Wada Y, Kojiro M. Combined hep-atocellular and cholangiocarcinoma: correlation between CT findings andclinicopathological features. J Comput Assist Tomogr 1997;21(1):52-8.